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ABSTRACT
Deamination of 5-methylcytosine to thymine creates
mutagenic G·T mispairs, contributing to cancer
and genetic disease. Thymine DNA glycosylase
(TDG) removes thymine from these G·T lesions,
and follow-on base excision repair yields a G·C
pair.Aprevious crystalstructure revealed TDG(cata-
lytic domain) bound to abasic DNA product in a 2:1
complex, one subunit at the abasic site and the other
bound to undamaged DNA. Biochemical studies
showed TDG can bind abasic DNA with 1:1 or 2:1
stoichiometry, but the dissociation constants were
unknown, as was the stoichiometry and affinity for
binding substrates and undamaged DNA. We
showed that 2:1 binding is dispensable for G·U
activity, but its role in G·T repair was unknown.
Using equilibrium binding anisotropy experiments,
we show that a single TDG subunit binds very
tightly to G·U mispairs and abasic (G·AP) sites, and
somewhat less tightly G·T mispairs. Kinetics experi-
ments show 1:1 binding provides full G·T activity.
TDG binds undamaged CpG sites with remarkable
affinity, modestly weaker than G·T mispairs, and
exhibits substantial affinity for nonspecific DNA.
While 2:1 binding is observed for large excess TDG
concentrations, our findings indicate that a single
TDG subunit is fully capable of locating and process-
ing G·Uo rG·T lesions.
INTRODUCTION
A large percentage of point mutations in cancer and
genetic disease are C!T transitions at CpG sites, result-
ing largely from replication of G·T mispairs created by
deamination of 5-methylcytosine (m
5C) to thymine (1–4).
Thymine DNA glycosylase (TDG) is charged with
ﬁnding these G·T lesions and removing thymine to
initiate base excision repair, which ultimately restores a
G·C base pair (5,6). Methyl binding domain IV (MBD4)
is another DNA glycosylase that processes G·T mispairs
arising from m
5C deamination at CpG sites (7,8). About
4% of cytosines in mammalian DNA are methylated,
selectively at CpG sites, and this key modiﬁcation
promotes transcriptional silencing and is essential for
many cellular processes and for embryonic development
(9). It is known that cytosine 5-methyltransferases
catalyze the conversion of C to m
5C at CpG sites in
DNA, but the mechanism for ‘demethylation’ of
m
5CpG has remained elusive (9). Several recent studies
indicate a BER-mediated pathway for active
demethylation (10,11); many indicate a mechanism for
active m
5C deamination, giving a G·T mispair that
could be processed by TDG (or MBD4) and BER to
restore a G·C pair (12–16). A preliminary report that
inactivation of TDG causes embryonic lethality in mice
(17), the ﬁrst such ﬁnding for any DNA glycosylase, is
consistent with an essential role for TDG in transcrip-
tional regulation, in addition to processing G·T mispairs
arising from spontaneous m
5C deamination.
Given the critical role of TDG in protecting against
C!T mutations and its emerging role(s) in transcription-
al regulation, it is important to obtain a detailed under-
standing of how TDG recognizes and processes lesions,
how its activity is stimulated by the follow-on BER
enzyme, APE1 and to characterize its interaction with
undamaged CpG sites and nonspeciﬁc DNA. Our
recent crystal structure of TDG (catalytic domain)
bound to abasic DNA (18) revealed a remarkable 2:1
complex, with one TDG subunit bound at the abasic
site and an adjacent subunit bound to undamaged
DNA (Figure 1). Such 2:1 binding had not previously
been observed for TDG, MUG or UNG. Our previous
biochemical studies showed TDG, full length and cata-
lytic domain, can bind abasic DNA with 1:1 or 2:1 stoi-
chiometry, depending on TDG concentration (18).
However, the afﬁnity for each TDG subunit (Kd1
and Kd2) remained unknown. Determining these values
is important for understanding the catalytic mechanism
of TDG and how its activity is stimulated by APE1, i.e.
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the stoichiometry for binding G·To rG·U substrates had
not been examined. Although we previously showed 1:1
binding provides full catalytic activity for G·U lesions
(18), TDG exhibits much weaker binding and catalysis
for G·T relative to G·U substrates (19–22), raising the
question of whether 2:1 binding could be needed for efﬁ-
cient G·T repair. This is important, because G·T lesions
are considered the predominant biological substrate for
TDG (21,23). Our previous studies demonstrate TDG
can excise bulky cytosine analogs from a CpG site in
DNA (24), suggesting TDG may have substantial afﬁnity
for undamaged CpG sites, but this had not been
determined. Additionally, previous studies suggest TDG
possesses signiﬁcant afﬁnity for nonspeciﬁc DNA (25),
but this has not been quantitatively examined.
Determining the afﬁnity and stoichiometry of TDG for
binding CpG sites and nonspeciﬁc DNA is important for
understanding its functions in DNA repair and transcrip-
tional regulation. We address these important questions
here using pre-steady-state kinetics and equilibrium
binding experiments.
MATERIALS AND METHODS
DNA synthesis and puriﬁcation
The DNA used for this work is shown in Figure 2. Duplex
DNA was hybridized by rapid heating to 80 C followed by
slow cooling to room temperature. DNA oligonucleotides
were synthesized at the Keck Foundation Biotechnology
Resource Laboratory of Yale University (trityl-on),
puriﬁed using Glen-Pak puriﬁcation cartridges (Glen
Research), and quantiﬁed by absorbance (260nm) as
described (22,24). Purity was veriﬁed by analytical
anion-exchange high-performance liquid chromatography
(HPLC) under denaturing (pH 12) conditions (24).
The oligonucleotides containing substrate analogs
20-deoxy-20-ﬂouroarabinothymidine (T
F, Figure 2) or
20-deoxy-20-ﬂouroarabinouridine (U
F) were obtained as
described (22). Control experiments demonstrate DNA
containing U
F or T
F is completely resistant to cleavage
by TDG (saturating concentration) for >48h, consistent
with previous ﬁndings for TDG (26) and MUG (27).
Previous studies and our ﬁndings here indicate T
F and
U
F are excellent mimics of dT and dU, and do not signiﬁ-
cantly perturb the structure of B-type DNA (22,26–29).
The DNA used for ﬂuorescence anisotropy experiments
was labeled with sulphorhodamine (Texas Red, TR) in the
non-target strand (50 amino C6 modiﬁer), and was
Figure 1. TDG can form a 2:1 complex with DNA. (A) Our previous
crystal structure shows TDG (catalytic domain) can form a 2:1 complex
with abasic DNA, one subunit (dark gray) binds the ﬂipped abasic
nucleotide and the adjacent subunit (light gray) binds to undamaged
DNA. The protein–protein interface buries  300A ˚ 2 of accessible
surface area per subunit. (B) Cartoon depicting the contacts to DNA
phosphates made by the speciﬁc TDG subunit (black triangles) and the
nonspeciﬁc subunit (gray triangles) with respect to the lesion site (red).
The DNA constructs used for the studies reported here are 16X11
(28bp) and 3X11 (15bp), where X represents the target nucleotide
(Figure 2). The 16X11 DNAs can accommodate 2:1 binding as
observed in the crystal structure, but the 3X11 DNAs cannot.
Figure 2. DNA used in this work. We used two non-cleavable
substrate analogs, 20-deoxy-20-ﬂouroarabinothymidine (T
F) and
20-deoxy-20-ﬂouroarabinouridine (U
F) to monitor TDG binding to
substrate in the absence of base excision. Two DNA constructs were
used; 16X11 can accommodate 2:1 binding as seen in the crystal structure,
while3X11cannot(Figure1).Thetargetnucleotide(x=U
F,T
F,AP,Tor
C) ispairedwith guanine(bold)andplaced inaCpGdinucleotidecontext,
in keeping with the speciﬁcity of TDG. The DNA contains no other CpG
site. The DNA was labeled at the 50 end of the non-target strand (*) with
sulforhodamine (also called Texas Red or TR) for anisotropy experiments
or with ﬂuorescein for EMSAs. The 28bp nonspeciﬁc DNA (NS28)
contains no mispair or CpG site.
2320 Nucleic Acids Research, 2011,Vol.39, No. 6synthesized and puriﬁed (RP-HPLC) by the Midland
Certiﬁed Reagent Co. (Midland, TX, USA).
Abasic (AP) DNA was generated by incubating 16U11
or 3U11 (2000nM) with a 1000-fold lower concentration
(2nM) of uracil DNA glycosylase (UNG) at 23 C for
30min, sufﬁcient time for complete conversion of sub-
strate to abasic product (16AP11 or 3AP11), and used
immediately for anisotropy or electrophoretic mobility
shift assay (EMSA) experiments. After dilution of AP
DNA (4000-fold) to the concentration used for anisotropy
(0.5nM), the residual UNG (0.0005nM) is far too dilute
to bind the AP DNA (Kd>15uM) (30) or effect the
binding of TDG. Although the higher AP–DNA concen-
tration used for EMSA (0.5mM) resulted in a higher
residual UNG concentration (0.5nM), given its weak
afﬁnity for AP DNA, and the 1000-fold excess concentra-
tion of AP DNA, UNG will have no effect on TDG
binding.
Enzyme puriﬁcation
Human thymine DNA glycosylase (TDG) was expressed
and puriﬁed as described (18,21), ﬂash frozen, and stored
at  80 C. The enzyme concentration is determined by ab-
sorbance, using a molar absorption coefﬁcient of
e
280=31.5mM
 1cm
 1, measured using the Edelhoch
method, as described (31). We typically ﬁnd TDG is
fully active, as indicated by observation that for
pre-steady-state multiple turnover kinetic experiments col-
lected for G·U and G·FU substrates, the amplitude of
the exponential phase is equal to the TDG concentration,
(Supplementary Figures S1 and S2).
Kinetics experiments
We used single turnover kinetics experiments under
saturating enzyme conditions ([E]>[S]>>Kd) to obtain
a rate constant (kmax) that is not inﬂuenced by product
release or product inhibition. This is important because
TDG exhibits very slow product release and strong
product inhibition, which dominates kcat values
determined using steady-state kinetics (19,32,33).
Experiments were collected at room temperature (23 C)
in HEMN.1 buffer (0.02M HEPES, 0.2mM EDTA,
2.5mM MgCl2, 0.1M NaCl). Experiments were initiated
by adding concentrated TDG to buffered substrate,
followed by rapid mixing. At various time points,
aliquots were removed, quenched with 50% (v:v) 0.3M
NaOH and 0.03M EDTA, and heated at 85 C for
15min to cleave the DNA backbone at enzyme-produced
abasic sites. The fraction product was determined by
HPLC (21,24). The data were ﬁtted to Equation (1)
using nonlinear regression with Graﬁt 6 (34):
fraction product ¼ Að1   e ktÞð 1Þ
where A is the amplitude, k is the rate constant and t is the
reaction time (min). The DNA substrate concentration
was 0.5mM, and the TDG concentration, 5mM, was
nearly 300-fold higher than the Kd for G·T substrate
binding determined here (see below). These saturating
enzyme conditions provide the maximal rate constant
for product formation (k&kmax).
We also determined the maximal rate of product forma-
tion using kinetics experiments as described above, but
with saturating substrate conditions ([S]>>Kd, and
[S]>>[E]) (22,33). The data were ﬁtted to Equation (2)
using nonlinear regression with Graﬁt 6:
product ðnMÞ¼Að1   e ktÞ+vt ð2Þ
where A and k are the amplitude and rate constant of the
exponential phase, v is steady-state velocity and t is time.
The steady-state rate constant (kcat) is calculated by
dividing steady-state velocity by enzyme concentration.
Fluorescence anisotropy experiments and data ﬁtting
Equilibriumbinding ofTDGtoDNAwas studiedbyﬂuor-
escence anisotropy using a QuantaMaster 40
spectroﬂuorometer (PTI), monitoring the ﬂuorescence
of sulphorhodamine (Texas Red, or TR) conjugated to
the 50-end of the non-target strand (Figure 2). Previous
studies show the beneﬁts of using X-rhodamine or
sulphorhodamine for monitoring protein nucleic acid
interactions by ﬂuorescence anisotropy (35–37). TDG
was titrated into HEMN.1 buffer (above) that contained
TR-labeled DNA, supplemented with 1% glycerol and
1uM BSA. The DNA concentration was maintained at a
ﬁxedvaluethroughoutthetitrationbyaddingconcentrated
enzyme in buffer that also contained DNA. After each
addition of TDG, the sample was incubated for at least
2min before data collection to ensure binding was at equi-
librium.This was conﬁrmed byobservation thattheanisot-
ropy was constant for at least 5min (for some data points).
Anisotropy data were collected in T-format, where one
PMT is connected directly to the sample compartment
(no monochromator) with wavelength selection provided
bya628-nmbandpassﬁlter(Semrock,Inc.).Theexcitation
wavelength was 590nm (3-nm band pass) and the
single-emission monochromator was set to 615nm (5-nm
band pass). Wavelength selection for the monochromators
was enhanced with 586 and 624nm band-pass ﬁlters
(Semrock, Inc.) for excitation and emission, respectively.
The equilibrium dissociation constants for TDG binding
to TR-labeled DNA were determined by ﬁtting the ﬂuor-
escence anisotropy data to appropriate models using
DynaFit 4 (38,39). The models and DynaFit scripts used
for data ﬁtting are given in the Supplementary Data. The
ﬁttedparameters included dissociation constantsforone or
two binding sites on the DNA, and anisotropy values for
free DNA (rD) and for 1:1 and 2:1 complexes with TDG
(rED and rEED). In many cases, the data clearly indicate two
nonequivalentbindingsites.Modeldiscriminationwasalso
informedbytheprobabilityvalueoftheFisher’sF-statistic,
obtained from data ﬁtting, where P<0.05 is considered
signiﬁcant. The reported parameters are derived from
global ﬁtting of at least two independent binding experi-
ments. We determined the equilibrium dissociation
constant for TDG binding to unlabeled DNA using equi-
librium competition anisotropy experiments, where TDG
binding to TR-labeled 16U
F11 was monitored in the
presence of varying concentrations of unlabeled DNA.
DynaFit was used for global ﬁtting of the data to a
model involving one or two TDG binding sites for the
Nucleic Acids Research,2011, Vol.39, No. 6 2321unlabeled DNA and two binding sites for TR-labeled
16U
F11. A beneﬁt of using DynaFit for the data presented
here is that data ﬁtting does not require an analytical
equation, which could involve assumptions that are not
compatible with experimental restraints. Indeed, the
standard model for two nonequivalent binding sites
assumes the species being monitored (DNA) is present at
much lower concentration than the dissociation constant.
This is not feasible for monitoring TDG binding to
16U
F11, because the minimal DNA concentration needed
for sufﬁcient sensitivity in the anisotropy experiment
(0.5nM) approximates the dissociation constant
(Kd1=0.6nM, see below).
Electrophoretic mobility shift assays
EMSAs were performed, essentially as described (18), to
provide an independent method for determining the stoi-
chiometry of TDG–DNA complexes. The EMSAs were
performed with precast 6% polyacrylamide native gels
(Invitrogen) and analyzed using a Typhoon 9400 imager
(GE Healthcare).
RESULTS
Experimental approach
We used ﬂuorescence anisotropy and EMSAs to determine
the afﬁnity and stoichiometry for TDG binding to DNA
containingaU
ForaT
F substrateanalog, anabasic (orAP)
site, an undamaged CpG site, and nonspeciﬁc DNA. We
and others have shown the U
F and T
F analogs are excellent
mimics of the natural dU and dT substrates, because they
allow formation of the catalytically competent enzyme–
substrate complex in the absence of base excision
(22,26,27,29). The U
F and T
F analogs differ from dU and
dT only by replacement of 20-H with ﬂuorine (20-ﬂuoro-
arabino, Figure 2), which renders the base-sugar
(N-glycosylic bond) of these and other nucleotides highly
resistant to spontaneous and enzymatic cleavage. Previous
studies show the 20-ﬂuoroarabino substitution, in dT and
other deoxynucleotides, promotes an O40-endo sugar
pucker (rather than C20-endo), which is fully compatible
with B-DNA geometry (28,40,41). Although the O40-endo
conformation in a substrate analog could potentially alter
the binding of a DNA glycosylase, our previous studies
indicate the effect is small for TDG binding to DNA con-
taining a T
F analog (22).
Our studies employed two different DNA lengths
(Figure 2), one that can accommodate 2:1 binding as
observed in the TDG AP–DNA crystal structure
(16X11, X=target nucleotide) and a shorter construct
(3X11) that lacks the nonspeciﬁc binding site seen in the
crystal structure (Figure 1). For all DNAs used here, the
target base is paired with guanine (i.e. G·T
F), in keeping
with the speciﬁcity of TDG (19,21).
For the ﬂuorescence anisotropy experiments, the DNA
was labeled with sulphorhodamine (Texas Red, TR) as
indicated in Figure 2. Previous studies indicate
sulphorhodamine and X-rhodamine are well suited for
characterizing protein–DNA interactions (35–37,42,43).
When conjugated to DNA, these ﬂuorophores are bright
and typically exhibit ﬂuorescence decay that is dominated
by a single lifetime and relatively independent of condi-
tions and protein binding, and their anisotropy is strongly
correlated with DNA rotation, with minimal contribution
from independent ﬂuorophore mobility. These properties
are highly desirable for studying protein–DNA inter-
actions, particularly for complex binding mechanisms as
shown below for TDG.
TDG binding to a G·U mispair
We ﬁrst consider equilibrium binding of TDG to 16U
F11,
which is long enough to accommodate 2:1 binding as
observed in the TDG·AP–DNA crystal structure
(Figure 3A). As shown in Figure 3B, the ﬂuorescence
anisotropy data clearly indicate two nonequivalent
binding sites, and ﬁtting to a two-site model reveals a
huge difference in afﬁnity, Kd1=0.63±0.16nM and
Kd2=662±108nM (Table 1). Thus, TDG forms a very
tight 1:1 complex with the G·U
F site, and a second TDG
subunit binds with 1000-fold weaker afﬁnity to give a 2:1
complex at high TDG concentrations. TDG binding to
16U
F11 was qualitatively assessed using an EMSA,
which conﬁrms the binding stoichiometry indicted by the
anisotropy data (Figure 3C).
We also examined TDG binding to 3U
F11, a DNA con-
struct which lacks the entire binding site for the second
TDG subunit of the 2:1 complex, as seen in the crystal
structure (Figure 1. The anisotropy data show TDG forms
a tight 1:1 complex with the G·U
F site of 3U
F11,
Kd1=8.4±2.9nM, and a second TDG subunit can
bind with very weak afﬁnity, Kd2=2650±463nM
(Figure 3D). The results of an EMSA conﬁrm this
binding stoichiometry (Figure 3E). Although 2:1 binding
to 3U
F11 is observed at high TDG concentrations, the
second subunit must bind an alternate site from that
seen in the crystal structure, as discussed below. Kinetics
experiments show this alternate 2:1 complex does not con-
tribute to G·U binding or processing, because catalytic
activity is nearly the same for conditions that give 2:1
binding (saturating TDG) or 1:1 binding (saturating sub-
strate, Supplementary Figure S.2). The ﬁnding that TDG
binds tightly to 3U
F11 shows the 2:1 complex observed in
the crystal structure is not required for speciﬁc recognition
of a G·U lesion, consistent with previous kinetics experi-
ments showing 2:1 binding is not needed for full G·U
catalytic activity (18).
A number of observations suggest the alternate 2:1
complex for 3U
F11 (and other 3X11 DNAs) involves tran-
sient and nonspeciﬁc binding of the catalytic domain and/
or the N-terminal region of TDG to DNA, and perhaps
some degree of protein-protein interactions. Sedimentation
velocity experiments show TDG is predominantly a
monomer at concentrations of 20 and 50mM
(Supplementary Figure S3). This indicates the alternate
2:1 complex, with Kd2=2.7mM (for 3U
F11), is not
comprised solely of protein–protein interactions (though
such interactions might be enhanced for DNA-bound
TDG). Previous studies show the disordered N-terminal
domain of TDG (residues 1–120) forms nonspeciﬁc inter-
actions with DNA (25,44), which may contribute to the
2322 Nucleic Acids Research, 2011,Vol.39, No. 6alternate 2:1 complex. Consistent with this, Kd2 is much
weaker for the catalytic domain (TDG-core, 111–308),
which binds 3U
F11 with Kd1=83±46nM and
Kd2=21±3mM (Supplementary Figure S4). Previous
sedimentation velocity experiments show TDG-core is
fully monomeric at 120mM (18). Thus, Kd2=21mM for
TDG-core binding to 3U
F11 suggests the catalytic
domain also exhibits nonspeciﬁc DNA interactions,
because DNA binding seems unlikely to promote
protein–protein interactions for TDG-core (18,45).
Although the detailed nature of the alternate 2:1 complex
is not presently clear, it only arises for large and excess
concentrations of TDG, and it does not substantially
alter catalytic activity.
TDG binding to a G·T mispair
The anisotropy and EMSA data for TDG binding to
16T
F11, a G·T substrate analog that can accommodate
2:1 binding, are shown in Figure 4A and B. Inspection of
the anisotropy data suggests two nonequivalent sites, and
ﬁttingtoatwo-site model revealstight bindingof oneTDG
subunit to the G·T
F site, Kd1=18±3nM, and weak
binding of a second TDG subunit to give a 2:1 complex,
Kd2=1279±279nM. The total change in anisotropy
(r=0.090) is nearly identical to that observed for
Figure 3. TDG binding to G·U
F substrate analogs monitored by ﬂuorescence anisotropy and EMSA. (A) Model for sequential 2:1 binding of TDG
to two different sites on a 28bp DNA with a 16X11 construct. (B) Anisotropy data for equilibrium binding of TDG to the 16U
F11 substrate analog
(0.5nM), obtained from two independent experiments (open circle, open rectangle). Fitting the data to a two-site binding model using DynaFit 4
gives Kd1=0.63±0.16nM and Kd2=662±108nM, and anisotropy values of rD=0.182, rED=0.220, rEED=0.275. (C) EMSA for TDG binding
to 16U
F11 (0.5uM), with the [TDG]:[DNA] ratio indicated. Arrows indicate anisotropy values or gel bands corresponding to free DNA (D), the 1:1
complex (ED), and the 2:1 complex (EED). (D) Anisotropy data for TDG binding to the 3U
F11 analog (0.5nM) from two independent experiments
(open circle, open rectangle). Fitting to a two-site binding model gives Kd1=8.4±2.9nM and Kd2=2650±463nM (and rD=0.144, rED=0.170,
rEED=0.247). (E) EMSA for TDG binding to 3U
F11 (0.5uM).
Table 1. Equilibrium dissociation constants for TDG binding to
speciﬁc and nonspeciﬁc DNA
DNA Kd1 (nM) Kd2 (nM) Kd2/Kd1
16U
F11 0.63±0.16 662±108 1051
3U
F11 8.4±2.9 2650±463 315
16T
F11 18±3 1279±279 71
3T
F11 124±25 818±80 7
16AP11 1.4±0.4 1926±762 1376
3AP11 6.2±1.3 3480±1173 561
16C11 63±10 965±148 15
NS28
a 293±64 1172±254 4
a
aParameters obtained from equilibrium competition experiments ﬁtted
to a model for two equivalent and independent binding sites (restrained
to Kd2=4*Kd1).
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F11 (r=0.093). The EMSA for TDG binding to
16T
F11 conﬁrms 1:1 binding at lower TDG:DNA ratios
and 2:1 binding at high TDG concentrations. The anisot-
ropy data for TDG binding to 3T
F11 (Figure 4C), which
cannot accommodate 2:1 binding (crystallographic), indi-
cates relatively tight binding to the G·T site,
Kd1=124±25nM, and weak binding of a second TDG
subunit, Kd2=818±80nM, to give an alternate 2:1
complex. The EMSA for TDG binding to 3T
F11 is consist-
ent with this binding stoichiometry (Figure 4D). The rela-
tively tight binding of TDG to 3T
F11 shows the 2:1
complex in the crystal structure is not required for
speciﬁc binding of TDG to a G·T mispair.
2:1 binding is not required for G·T repair activity
Our results indicate 2:1 binding to G·T mispairs is highly
unlikely under limiting enzyme conditions, because Kd2 is
weak, and Kd2>>Kd1. Nevertheless, we sought to deter-
mine whether 2:1 binding, if it occurs, could enhance
catalytic activity for G·T substrates. We showed previous-
ly that 2:1 binding is dispensable for G·U activity (18),
but the result could potentially differ for G·T activity,
since binding and catalysis is much weaker for G·T
relative to G·U substrates (Table 1) (19,22). We used
single turnover kinetics experiments with saturating
TDG (5000nM) and limiting G·T substrate (500nM)
such that 2:1 binding predominates. As shown in
Figure 5A, the maximal rate of base excision is the same
for a G·T substrate that can accommodate 2:1 binding
(kmax=0.16±0.03min
 1) and one that cannot
(kmax=0.14±0.03min
 1). We conclude 2:1 binding
does not enhance catalytic activity for G·T substrates.
We also approached this question using pre-steady-
state multiple turnover kinetics, collected with saturating
G·T substrate (2000nM) and limiting TDG (200nM),
such that 2:1 binding is negligible (Figure 5B). Under
these conditions, TDG exhibits an exponential phase,
kobs=0.12±0.02min
 1, reﬂecting the maximal rate of
base excision, followed by a much slower steady-state
Figure 4. TDG binding to G·T
F substrate analogs monitored by ﬂuorescence anisotropy and EMSAs. (A) Anisotropy data for equilibrium binding
of TDG to 16T
F11 (0.5nM), obtained from two independent experiments (open circle, open rectangle). Fitting to a two-site binding model gives
Kd1=18±3nM, and Kd2=1279±279nM (and anisotropy of rD=0.189, rED=0.237, rEED=0.278). (B) EMSA for TDG binding to 16T
F11
(0.5uM); the [TDG]:[DNA] ratio is indicated. (C) Anisotropy data for TDG binding to 3T
F11 (0.5nM) obtained from two independent experiments
(open circle, open rectangle). Fitting to a two-site model gives Kd1=124±25nM, and Kd2=818±80nM (and rD=0.150, rED=0.176,
rEED=0.273). To obtain a proper ﬁt it was necessary to ﬁx rED=0.176, which is based on rD=0.150 (ﬁtted for 3T
F11) and r for 1:1 binding
to 3U
F11 (r1:1=rED rD=0.026). (If rED is not ﬁxed, Kd2 and rEED are poorly constrained and unreasonably high). The data are better ﬁtted to a
two-site rather than one-site binding model (P =0.011). Moreover, 2:1 binding to 3T
F11 is indicated by observation that the total anisotropy change
is slightly larger for 3T
F11 (rEED rD=rtot=0.123) than for 3U
F11 (rtot=0.103), for which 2:1 binding is demonstrated by anisotropy and
EMSA. (D) EMSA for TDG binding to 3T
F11 (0.5uM). Low population of the 2:1 complex at the highest TDG:DNA ratio is likely due to
dissociation during electrophore2sis, as 3T
F11 exhibits very rapid dissociation (koff) from TDG (unpublished data).
2324 Nucleic Acids Research, 2011,Vol.39, No. 6phase (33). Observation that the maximal base excision
rate is nearly the same for conditions of saturating TDG
or saturating G·T substrate conﬁrms that 2:1 binding, if it
occurs, does not substantially enhance G·T activity.
TDG binding to abasic DNA product
It is also important to determine the stoichiometry and
afﬁnity for TDG binding to its abasic (or AP) DNA
product. Anisotropy data for TDG binding to 16AP11
DNA, which contains a G·AP site and is long enough
to accommodate 2:1 binding, are shown in Figure 6A.
The anisotropy data indicate two nonequivalent sites,
and ﬁtting to a two-site model reveals tight binding of
one TDG subunit to the AP site, Kd1=1.4±0.4nM
and very weak binding of a second TDG subunit to give
a 2:1 complex, Kd2=1926±762nM. The EMSA for
TDG binding to 16AP11 (Figure 6B) conﬁrms the
binding stoichiometry indicated by anisotropy; 1:1
binding at lower TDG:DNA ratios and 2:1 binding for
large and excess TDG concentrations.
Anisotropy data for TDG binding to 3AP11 indicates
relatively tight binding to the G·AP site,
Kd1=6.2±1.3nM, and very weak binding of a second
TDG subunit to give an alternate 2:1 complex,
Kd2=3480±1173nM (Figure 6C). The stoichiom-
etry and relative afﬁnities indicated by the anisotropy
experiments are qualitatively conﬁrmed by an EMSA
(Figure 6D). The tight binding of a single TDG
subunit to 3AP11 shows that a second TDG subunit
is not required for speciﬁc binding to a G·AP product
site.
TDG binding to an undamaged CpG site
It is known that TDG is speciﬁc for G·T mispairs and
other lesions located in a CpG sequence context
(19,21,23,46), but the afﬁnity of TDG for an undamaged
CpG site had not been determined. Such knowledge is
important for understanding how TDG locates G·T
mispairs arising at CpG sites and its role(s) in transcrip-
tional regulation. We previously showed TDG exhibits
exceedingly low activity for cleaving cytosine from a
CpG site (<1% product in 8h), thus binding studies can
be performed in the absence of base cleavage (24).
Anisotropy and EMSA data for TDG binding to 28-bp
DNA containing a CpG site (16C11) are shown in
Figure 7A and 7B. The anisotropy data indicate that
TDG binds the CpG site with remarkably tight afﬁnity,
Kd1=63±10nM, and a second TDG subunit binds with
much weaker afﬁnity, Kd2=965±148nM, at high TDG
concentrations. The EMSA conﬁrms the stoichiometry
indicated by the anisotropy data.
Figure 6. TDG binding to abasic (AP) DNA product monitored by
ﬂuorescence anisotropy and EMSA. (A) Anisotropy data for equilib-
rium binding of TDG to 16AP11 (0.5nM). Fitting to a two-site binding
model gives Kd1=1.4±0.4nM and Kd2=1926±762nM (and anisot-
ropy of rD=0.178, rED=0.233, rEED=0.276). Due to slow dissoci-
ation of AP DNA from TDG, the anisotropy data were collected using
individual samples that were incubated for at least 2h prior to data
collection to ensure equilibration. Our unpublished data by
stopped-ﬂow and other kinetic methods show 2h is sufﬁcient for equili-
bration (conﬁrmed in some cases by repeating measurements after add-
itional equilibration time). (B) EMSA for TDG binding to 16AP11
(0.5uM), with the [TDG]:[DNA] ratio indicated. (C) Anisotropy data
for TDG binding to 3AP11 (0.5nM) obtained from two independent
experiments (open circle, open rectangle). Fitting to a two-site binding
model gives Kd1=6.2±1.3nM and Kd2=3480±1173nM (and an-
isotropy of rD=0.144, rED=0.200 and rEED=0.271). (D) EMSA
for TDG binding to 3AP11 (0.5uM).
Figure 5. Kinetics experiments show 2:1 binding is not needed for pro-
cessing G·T substrates. (A) Single turnover kinetics collected with
saturating TDG (5000nM) and limiting G·T substrate (500nM), one
of which can accommodate 2:1 binding (16T11, open circle) and one
that cannot (4T11, open rectangle). Fitting the data (multiple experi-
ments) to Equation (1) gives kmax=0.16±0.03min
 1 (16T11) and
kmax=0.14±0.03min
 1 (4T11). We note that 4T11 is the minimal
DNA construct that provides full G·T activity, due likely to
non-speciﬁc interactions between the DNA (50 of the dT target) and
the N-terminal region of TDG (unpublished data). However, 4T11 still
lacks the entire binding site for the second TDG subunit as seen in the
crystal structure (Figure 1). (B) Pre-steady-state multiple-turnover
kinetics collected with saturating G·T substrate (2000nM) and
limiting TDG (200nM). Fitting the data (multiple experiments) for
16T11 (open circle) to Equation (2) gives a rate constant of
kobs=0.12±0.02min
 1 and amplitude A=134±3nM for the expo-
nential phase, and a rate constant of kcat=0.0006±0.0003min
 1 for
the steady-state phase. The parameters are very similar for 4T11 (open
rectangle); kobs=0.12±0.02min
 1, A=117±3nM, and
kcat=0.0002±0.0001min
 1. Observation of slightly greater amplitude
for 16T11 indicates 1:1 binding to both substrates, because 4T11 cannot
accommodate 2:1 binding, consistent with other results above. For
G·T substrates, we typically ﬁnd A<[TDG]. However, for G·U and
G·FU substrates, we ﬁnd A= [TDG], indicating TDG is fully active
(Supplementary Figure S1). We are currently investigating the basis of
the diminished amplitude for G·T substrates. However, this does not
alter our conclusion that 2:1 binding is not needed for G·T activity.
Nucleic Acids Research,2011, Vol.39, No. 6 2325To obtain another measure of TDG afﬁnity for an un-
damaged CpG site, we performed equilibrium competition
experiments, by collecting anisotropy data for TDG
binding to 16U
F11 (labeled) in the presence of two differ-
ent concentrations of unlabeled 16C11 (Figure 7C).
Global ﬁtting of all the data to a model describing two
TDG binding sites for 16U
F11 and 16C11 gives
Kd1=26±8nM for 1:1 binding to 16C11, but Kd2 is
poorly constrained by the data (and unreasonably large).
The global ﬁtting provides another measure of TDG
afﬁnity for 16U
F11 in the presence of a DNA competitor,
giving dissociation constants identical to those obtained in
the absence of 16C11. Our results show TDG binds tightly
to undamaged CpG sites, with an afﬁnity that is merely
4-fold lower than for G·T mispairs.
TDG binding to nonspeciﬁc DNA
To gain perspective on the binding afﬁnity of the second
TDG subunit (Kd2) of the 2:1 complex, which binds a
nonspeciﬁc region of DNA (Figure 1), we determined
the afﬁnity of TDG for binding DNA that is entirely
nonspeciﬁc (contains no mispair or CpG site). We
determined the afﬁnity of TDG for 28-bp nonspeciﬁc
DNA (NS28) using equilibrium competition binding ex-
periments, by collecting anisotropy data for TDG binding
to 16U
F11 (labeled) in the presence of ﬁxed concentrations
of unlabeled NS28 (Figure 8A). Global ﬁtting of data col-
lected in the presence and absence of NS28 to a competi-
tive model describing two binding sites for 16U
F11 and
two equivalent and independent binding sites for NS28
Figure 7. TDG binding to DNA containing a single CpG site, monitored by ﬂuorescence anisotropy and an EMSA. (A) Anisotropy data for
equilibrium binding of TDG to the 28-bp 16C11 DNA (0.5nM) obtained from two independent experiments (open circle, open rectangle). Fitting to
a two-site binding model gives Kd1=63±10nM,andKd2=965±148nM (and anisotropy of rD=0.180, rED=0.223, rEED=0.275). To obtain a
good ﬁt, it was necessary to ﬁx rED=0.223. This value is the sum of rD=0.180 (ﬁtted for 16C11) and r1:1=0.043 (average of r1:1 values for
16U
F11 and 16T
F11). Otherwise, the ﬁtted rED is unreasonably high (0.25), and Kd2 and rEED are poorly constrained. The data are better ﬁtted to
model for two-site versus one-site binding (dashed line, P=0.010). (B) EMSA for TDG binding to 16C11 (0.5uM), with the [TDG]:[DNA] ratios
given. (C) Equilibrium competition anisotropy experiments for TDG binding to TR-labeled 16U
F11 (0.5nM) collected in the absence of 16C11 (open
circle and open triangle, data from Figure 3B) and in the presence of 16C11 at a concentration of 50nM (open rectangle) or 125nM (open rhombus).
The data were ﬁtted globally to model with two TDG binding sites for 16U
F11 and 16C11, giving Kd1=26±8nM for 16C11, and
Kd1=0.59±0.14nM and Kd2=673±100nM for 16U
F11 (anisotropy for 16U
F11 of rD=0.182, rED=0.221, rEED=0.274). Kd2 for 16C11 is
poorly constrained by the data (and unreasonably large). Fitting the data to a competition model with one site for 16C11 gives the same Kd1 (within
error). However, the data in (A) and (B) show TDG can form a 2:1 complex with 16C11.
Figure 8. TDG binding to nonspeciﬁc DNA monitored ﬂuorescence anisotropy and an EMSA. (A) Equilibrium competition anisotropy experiments
for TDG binding to TR-labeled 16U
F11 (0.5nM) collected in the absence of NS28 (open circle, open triangle) and with NS28 concentrations of
200nM (open rectangle) or 500nM (open rhombus). Global ﬁtting of all data to model involving two TDG binding sites for 16U
F11 and two
equivalent and independent sites for NS28 (i.e. restrained to Kd2=4*Kd1) gives Kd1=293±64nM and Kd2=1172±254nM for NS28. For
16U
F11, the ﬁtting gives Kd1=0.88±0.13nM and Kd2=654±62nM (and anisotropy of rD=0.189, rED=0.221, rEED=0.278). Fitting the
data to a model involving a single site for NS28 gives essentially the same result for NS28 binding, Kd1=279±69nM, and for the 16U
F11
parameters (data not shown). (B) EMSA for TDG binding to 28bp nonspeciﬁc DNA (NS28, 0.5uM) with the [TDG]:[DNA] ratio indicated.
2326 Nucleic Acids Research, 2011,Vol.39, No. 6(i.e. restrained to Kd2=4*Kd1) gives Kd1=293±64nM
and Kd2=1172±254nM. The latter value falls in the
range of Kd2 values for other DNAs examined here
(Table 1). Fitting the data to a model with just one site
for NS28 gives essentially the same result,
Kd1=279±69nM. However, the two-site model is con-
sistent with a binding analysis by EMSA (Figure 8B),
which shows a 1:1 complex at lower [TDG]/[NS28]
ratios and a 2:1 complex for large and excess TDG con-
centrations. Global ﬁtting of the data in Figure 8A also
provides a measure of TDG afﬁnity for 16U
F11 in the
presence of nonspeciﬁc DNA, and gives essentially the
same dissociation constants as obtained in the absence
of NS28. Our ﬁndings show TDG possesses substantial
afﬁnity for nonspeciﬁc DNA.
DISCUSSION
The remarkable observation from previous structural
and biochemical studies that TDG can bind abasic DNA
with 1:1 or 2:1 stoichiometry (18) raised the important
questions of whether 2:1 binding contributes to the
ability of TDG to ﬁnd and initiate the repair of G·T and
G·U lesions or to the mechanism by which APE1 stimu-
lates TDG activity. We investigated these questions by
determining the stoichiometry and afﬁnity for TDG
binding to a G·Uo rG ·T substrate analog, an abasic
site, an undamaged CpG site, and to nonspeciﬁc DNA.
Our ﬁndings provide insight into how TDG recognizes
and processes G·U mispairs. TDG forms a very tight 1:1
complex with a G·U mispair (Kd1=0.6nM, Table 1), and
a second subunit can bind with much weaker afﬁnity
(Kd2=660nM) for high concentrations of TDG that are
in great excess over G·U DNA. The tight binding to a
G·U mispair observed here is consistent with previous
results using DNA containing a G·U
F analog (26).
TDG also binds tightly to 3U
F11 (Kd=8nM), showing
the 2:1 complex observed in the TDG crystal structure is
not needed for speciﬁc recognition of a G·U mispair. This
is consistent with our previous kinetics experiments
showing 1:1 binding provides full G·U catalytic activity
(18). The 1000-fold difference in binding afﬁnity for the
two sites of the 2:1 complex, and the weak afﬁnity of the
second site relative to nonspeciﬁc DNA (NS28), indicates
that under conditions of limiting enzyme and a huge
excess of nonspeciﬁc DNA, TDG processes G·U lesions
with 1:1 stoichiometry. This conclusion is supported by
previous footprinting experiments, which indicated 1:1
binding to DNA containing a G·U
F analog under condi-
tions of limiting TDG (26). However, given that other
glycosylases process G·U lesions much more efﬁciently
than TDG, the more relevant question is whether 2:1
binding contributes to repair of G·T lesions, the
primary biological target of TDG.
Our results indicate that TDG also binds and processes
G·T lesions with 1:1 stoichiometry. TDG binds tightly
to 28bp DNA containing a G·T substrate analog
(Kd1=18nM), and a second subunit binds with much
weaker afﬁnity (Kd2=1280nM) for large and excess
concentrations of TDG. The large difference in afﬁnity
for the two sites (Kd2/Kd1=71) and the weak afﬁnity of
TDG for the second site (Kd2) relative to nonspeciﬁc DNA
indicates 2:1 binding to G·T mispairs is unlikely for
cellular conditions of limiting TDG and a large excess of
nonspeciﬁc DNA. Moreover, the relatively tight afﬁnity of
TDG for 3T
F11 indicates the 2:1 complex is not needed
for speciﬁc recognition of G·T lesions. Finally, our
kinetics experiments show that 1:1 binding provides full
catalytic activity for G·T processing.
We ﬁnd TDG binds a G·T mispair with about 30-fold
weaker afﬁnity than a G·U mispair. This is likely ex-
plained by the methyl group at C5 of thymine (uracil
has hydrogen at C5), which may diminish the lifetime of
the dT nucleotide in the ﬂipped state due to steric hin-
drance in the TDG active site, as suggested by our
previous kinetics results (21,22,24). Given that G·T
lesions arising at CpG sites are likely the predominant
biological target of TDG (21,23), one might expect TDG
to have evolved to bind more tightly to G·T mispairs. The
weaker afﬁnity for G·T mispairs may reﬂect a comprom-
ise between the competing needs for efﬁcient processing of
G·T lesions and avoiding the excision of T from the huge
excess of A·T base pairs, which is governed in part by the
18000-fold speciﬁcity of TDG for excising T from G·T
versus A·T pairs (21).
Previous studies show TDG binds tightly to its AP
DNA product, and that AP DNA is a potent inhibitor
of the TDG reaction (32,33,47). Our anisotropy results
here show TDG forms a very tight 1:1 complex with its
reaction product, a G·AP site (Kd1=1.4nM), and a
second subunit binds with much weaker afﬁnity
(Kd2=1.9mM) for large and excess concentrations of
TDG. The huge difference in afﬁnity for the two sites
(Kd2/Kd1=1376) and the weak afﬁnity of TDG for the
second site (Kd2) relative to nonspeciﬁc DNA indicates
2:1 binding to abasic sites is unlikely for cellular condi-
tions of limiting TDG and excess nonspeciﬁc DNA. The
conclusion that a second TDG subunit is not needed for
tight binding to G·AP sites is supported by the high
afﬁnity of TDG for 3AP11 (Kd1=6nM).
Our ﬁndings have important implications for the stimu-
lation of TDG activity by the follow-on base excision
repair enzyme, APE1 (32). We previously showed that
APE1 greatly enhances TDG activity, increasing its rate
of steady-state turnover (kcat) by 42- and 26-fold for G·T
and G·U substrates, respectively (33). Our results here
indicate that under the conditions used for these
previous studies, limiting concentrations of TDG (and
APE1) and a saturating amount of TDG substrate,
TDG binds its product with 1:1 stoichiometry. Thus, the
stimulatory effect of APE1 does not involve a TDG
product complex with 2:1 stoichiometry. Consistent with
this conclusion, we previously observed potent stimulation
of TDG by APE1 for a short DNA that cannot accom-
modate two TDG subunits (3U12 substrate or 3AP12
product) (33). Together, these studies indicate the stimu-
latory effect of APE1 involves a TDG product complex
with 1:1 stoichiometry.
The afﬁnity of TDG for an undamaged CpG site had
not been quantitatively examined, despite the strong
speciﬁcity of TDG for G·T mispairs (and other
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ﬁnd TDG binds DNA containing a CpG site (16C11) with
remarkable afﬁnity, Kd1=63nM, about 4-fold weaker
than its afﬁnity for the same DNA containing a G·T
lesion (Table 1). The speciﬁcity for a CpG site is also
indicated by observation that TDG binds 4-fold tighter
to 16C11 than to nonspeciﬁc DNA (NS28) that contains
no CpG site but is otherwise identical. On an experimental
note, our ﬁndings indicate that studies of TDG binding to
a particular site (i.e. a G·T mispair) should use DNA that
does not contain an undamaged CpG site.
Preferential binding to CpG requires a mechanism for
recognizing these sites within a large background of
nonspeciﬁc DNA. Previous studies suggest TDG may ac-
complish this by transiently ﬂipping 20-deoxycytidine (dC)
out of a CpG site and into its active site (or ﬂipping it
partially into the active site). Our crystal structure indi-
cates speciﬁcity for excising lesions from a CpG site
involves interactions with the 30-guanine (50-XpG,
X=lesion) that cannot be formed in the absence of nu-
cleotide ﬂipping (18), which suggests nucleotide (dC)
ﬂipping may be required for recognizing undamaged
CpG sites. The ability of TDG to ﬂip dC into its active
site is indicated by our previous ﬁnding that TDG can
cleave analogs of dC that have a weakened N-glycosylic
bond (e.g. 5-ﬂuoro-dC, 5-hydroxy-dC, etc.) (24).
However, these results do not rule out a mechanism
whereby TDG recognizes CpG sites in the absence of nu-
cleotide ﬂipping. Further studies are needed to resolve this
question.
The ability of TDG to bind CpG sites and transiently
ﬂip dC into its active site, suggested by the ﬁndings
herein and in our previous studies, may be important
in the search for G·T lesions arising from deamination
of m
5C, a modiﬁed base found selectively at CpG sites.
In addition, the afﬁnity of TDG for undamaged CpG
sites and nonspeciﬁc DNA may be important for its
ability to modulate the activity of transcription factors
including retinoic acid and retinoid X receptors (48),
estrogen receptor a (49) and thyroid transcription
factor 1 (50), and co-activators such as CBP/p300 (51).
Additional studies are needed to explore these ideas
further.
In summary, we ﬁnd TDG binds tightly to G·U and
G·T mispairs, with subnanomolar and low nanomolar
afﬁnity, respectively, and that 1:1 binding provides full
G·T repair activity. TDG forms a very tight 1:1
complex with abasic (G·AP) sites, indicating the stimula-
tory effect of APE1 does not require 2:1 binding of TDG
to its product. TDG binds tightly to undamaged CpG
sites, about 4-fold weaker than to G·T mispairs, and it
exhibits substantial afﬁnity for nonspeciﬁc DNA. While
2:1 binding to DNA is observed in vitro for large and
excess concentrations of TDG, our results indicate that
a single TDG subunit is fully capable of ﬁnding and pro-
cessing G·U and G·T lesions.
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